In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Ceftriaxone, Disodium Salt, Hemiheptahydrate Drug Master File in Korea (Ceftriaxone, Disodium Salt, Hemiheptahydrate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ceftriaxone, Disodium Salt, Hemiheptahydrate. The MFDS reviews the Ceftriaxone, Disodium Salt, Hemiheptahydrate KDMF as part of the drug registration process and uses the information provided in the Ceftriaxone, Disodium Salt, Hemiheptahydrate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Ceftriaxone, Disodium Salt, Hemiheptahydrate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ceftriaxone, Disodium Salt, Hemiheptahydrate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Ceftriaxone, Disodium Salt, Hemiheptahydrate suppliers with KDMF on PharmaCompass.